PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Biohaven Pharma (BHVN) CEO Buys Another $400K in Stock
November 1, 2022 8:19 AM EDTBiohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.
The value of the purchase was $411,995.
Yesterday, Coric disclosed the purchase of $2.1 million in stock.
... MorePfizer (PFE) Tops Q3 EPS by 34, Beats on Revenue; Offers FY Guidance
November 1, 2022 6:47 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $1.78, $0.34 better than the analyst estimate of $1.44. Revenue for the quarter came in at $22.6 billion versus the consensus estimate of $21.33 billion.
GUIDANCE:
Pfizer sees FY2022 EPS of $6.30-$6.45, versus the consensus of $6.38. Pfizer sees... More
